C22.2 is the authoritative medical code for Hepatoblastoma. This classification is used in medical billing and clinical recording to specify the clinical criteria for hepatoblastoma (ICD-10-CM C22.2), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Sequencing, inclusion, and exclusion notes published for C22.2 in the official ICD-10-CM tabular list.
Conditions that can never be reported with this code; the two are mutually exclusive.
Conditions not covered by this code, but which may be reported alongside it when both are present.
Supplementary codes the tabular list directs you to add.
Per Excludes1 instructions, C22.2 must not be reported with: malignant neoplasm of biliary tract NOS (C24.9); secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7); Kaposi's sarcoma of gastrointestinal sites (C46.4).
Per Excludes2 instructions, C22.2 and the following may both be reported when both are present: gastrointestinal stromal tumors (C49.A-).
Use additional code(s) to specify: code to identify:; alcohol abuse and dependence (F10.-); hepatitis B (B16.-, B18.0-B18.1); hepatitis C (B17.1-, B18.2).
Official ICD-10-CM classifications in the same code family as C22.2, with their registry titles.
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code.
Anatomical sites from the official ICD-10-CM Table of Neoplasms that map to this code, with the matching behavior column.
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: